Type
Business expansion
Country
Slovenia
Region
Slovenija; Zahodna Slovenija; Osrednjeslovenska
Location of affected unit(s)
Ljubljana
Sector
Manufacturing
(20 - 21) Manufacture of chemicals and pharmaceuticals
21.2 - Manufacture of pharmaceutical preparations
21.20 - Manufacture of pharmaceutical preparations

121 jobs
Number of planned job creations
Job creation
Announcement Date
2 July 2026
Employment effect (start)
2 July 2026
Foreseen end date
31 December 2026

Description

Novartis, the Swiss pharmaceutical company, has opened a new aseptic products facility in Ljubljana, creating 121 new jobs.

Novartis has invested €200 million in a facility for manufacturing and packaging aseptic medicines, mainly in liquid form, which are filled into syringes or vials during production. The company plans to create 121 new jobs at the Ljubljana facility.

The opening is part of Novartis’ €600 million investment across multiple sites in Slovenia, focusing on constructing development and production facilities and introducing new technologies.


Citation

Eurofound (2026), Novartis, Business expansion in Slovenia, factsheet number 300850, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/300850.